首页> 外文期刊>Medical Microbiology and Immunology >A Listeria adhesion protein-deficient Listeria monocytogenes strain shows reduced adhesion primarily to intestinal cell lines.
【24h】

A Listeria adhesion protein-deficient Listeria monocytogenes strain shows reduced adhesion primarily to intestinal cell lines.

机译:缺乏李斯特菌粘附蛋白的单核细胞增生李斯特菌菌株显示出减少的粘附力,主要是与肠道细胞系的粘附力降低。

获取原文
获取原文并翻译 | 示例
           

摘要

Listeria monocytogenes adheres and penetrates intestinal cell linings for systemic infection. A 104-kDa Listeria adhesion protein (LAP) from L. monocytogenes was previously demonstrated to be responsible for adhesion to intestinal enterocyte-like Caco-2 cells. We investigated the adhesion and invasion characteristics of a LAP-deficient mutant L. monocytogenes strain (A572) to various human intestinal and non-intestinal cell lines to assess the possible target host cells. Among the intestinal cell lines, A572 showed significantly reduced adhesion than the wild type (WT) strain to the cells of ileum-cecum (HCT-8) and colon (Caco-2 and HT-29), whereas A572 and WT did not show any significant differences in adhesion to other intestinal cell lines from duodenum (HuTu-80) or jejunum (Int-407). Differences in adhesion between A572 and WT were little or none in non-intestinal cell lines from liver, kidney, bladder, ovary, cervix, breast, larynx, or skin. Invasion data showed that A572 was invasive but the invasion efficiency was proportional to its adhesion characteristics to respective cell lines. In mouse bioassay, A572 was not found in liver following oral administration, suggesting that LAP mutant was possibly unable to pass through intestinal cell linings. Immuno-electron microscopy revealed that the LAP is localized in the bacterial surface as well as the cytoplasm. In summary, this study indicated that the LAP-mediated adhesion is associated with the intestinal cells originating from the lower part of small intestine and from the upper part of large intestine, and possibly plays an important role during the intestinal phase of infection.
机译:单核细胞增生性李斯特菌粘附并穿透肠道细胞内膜进行全身感染。先前已证明,来自单核细胞增生李斯特氏菌的104 kDa李斯特菌粘附蛋白(LAP)负责与肠肠细胞样Caco-2细胞的粘附。我们调查了一个LAP缺陷型单核细胞增生李斯特氏菌菌株(A572)对各种人类肠道和非肠道细胞系的粘附和侵袭特性,以评估可能的靶宿主细胞。在肠道细胞系中,与野生型(WT)菌株相比,A572对回肠盲肠(HCT-8)和结肠(Caco-2和HT-29)细胞的粘附力显着降低,而A572和WT没有显示与十二指肠(HuTu-80)或空肠(Int-407)对其他肠细胞系的粘附力有任何显着差异。在来自肝,肾,膀胱,卵巢,子宫颈,乳腺,喉或皮肤的非肠道细胞系中,A572和WT之间的粘附差异很小或没有。侵袭数据显示A572具有侵袭性,但是侵袭效率与其对各个细胞系的粘附特性成正比。在小鼠生物测定中,口服后在肝脏中未发现A572,这表明LAP突变体可能无法通过肠道细胞内壁。免疫电子显微镜显示,LAP位于细菌表面以及细胞质中。总而言之,这项研究表明,LAP介导的粘附与源自小肠下部和大肠上部的肠细胞有关,并且可能在感染的肠道阶段起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号